Authors: Jonasch, E Kumar, UN Linette, GP Hodi, FS Soiffer, RJ Ryan, BF Sober, AJ Mihm, MC Tsao, H Langley, RG Cosimi, BA Gadd, MA Tanabe, KK Souba, W Haynes, HA Barnhill, R Osteen, R Haluska, FG

Citation: E. Jonasch et al., Adjuvant high-dose interferon alfa-2b in patients with high-risk melanoma, CANCER J, 6(3), 2000, pp. 139-145

Authors: Linette, GP Shankara, S Longerich, S Yang, SX Doll, R Nicolette, C Preffer, FI Roberts, BL Haluska, FG

Citation: Gp. Linette et al., In vitro priming with adenovirus/gp100 antigen-transduced dendritic cells reveals the epitope specificity of HLA-A0201-restricted CD8(+) T cells in patients with melanoma, J IMMUNOL, 164(6), 2000, pp. 3402-3412

Authors: Yang, SX Linette, GP Longerich, S Roberts, BL Haluska, FG

Citation: Sx. Yang et al., HLA-A2.1/K-b transgenic murine dendritic cells transduced with an adenovirus encoding human gp100 process the same A2.1-restricted peptide epitopes as human antigen-presenting cells and elicit A2.1-restricted peptide-specific CTL, CELL IMMUN, 204(1), 2000, pp. 29-37